Executive Director, Government Affairs, Europe

Revolution Medicines Switzerland Posted 29 Jun 2026

About this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revo…

How to apply

Applications are handled by the employer. Open the original advert to apply, or create a free NextMove account to track deadlines and see similar matches.